Source : NanoInk, Inc
SKOKIE, Ill. – January 10, 2012 – The Nano BioDiscovery™ Division of NanoInk®, Inc. announced
today the release of a new automated platform for the analysis of its protein NanoArray assays.
NanoInk’s NanoArray Assay System
™
enables detection, identification, and quantitation of clinically
relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker
analysis, translational medicine, and toxicology. NanoInk assays consume much smaller sample and
reagent volumes than do traditional ELISA and bead-based assays, generating more proteomic data with
less starting material and lowering assay costs for tests that are typically expensive to run.
These benefits are fully explained in a state-of-the-art high definition video entitled,
“NanoArray Assays:
More Proteomic Data from Less Sample,”
and is now available on NanoInk’s Web site. With the aid of
3D animation, scientist interviews, and HD videography, the NanoInk platform comes alive.
http://nanoink.net/protein_analysis/multi-media.html
As the video demonstrates, NanoInk’s assays provide customers the choice of automated proteomic
analysis or simple bench top testing using standard immunoassay protocols; both formats are fully
detailed. The automated format combines a small sample size advantage with the additional benefit of
high-throughput precision and speed. The latest NanoInk assay kits include all protocols, reagents, and
SBS compliant consumables needed to conduct NanoArray studies on commercially available lab
automation systems. Additionally, NanoInk array slides are compatible with 96 and 384-well sample
microplates. Customers can automate nanoscale proteomic analysis in their own lab or outsource these
projects to NanoInk’s expert contract service team.
The ability to generate high-throughput proteomic data from very small sample volumes is especially
critical when working with rare and hard-to-collect samples like rodent serum, spinal fluid, tissue
extracts, rodent urine, saliva, sweat, tears, and dried blood spots. Whether using the automated or
manual assay format, NanoInk’s miniaturized immunoassay platform can extract multiplexed protein
biomarker data from just 2 μl of sample.
According to Bruce Dudzik, Vice President of the Nano BioDiscovery Division, “Life science
researchers who find it difficult to extract usable protein biomarker data from limited sample volumes
will find that the NanoInk platform enables them to successfully analyze more samples, faster.”
The NanoArray Assay System is a user friendly, affordable desktop unit that can quickly and cost-
effectively integrate into any proteomic lab. It can create highly reproducible protein arrays over
millimeter areas with nanometer precision and then can fluorescently image these NanoArrays with 0.5
μm resolution. With these exquisitely precise array deposition and ultra-high resolution detection
capabilities, the NanoInk platform can achieve sub-picogram sensitivities with 2 μl or less of sample.
This is comparable to or better than the sensitivity of ELISA and bead-based assays that require 50 μl or
more of sample.
NanoInk’s new video demonstrates how the company helps its customers address major proteomic
challenges with automated and miniaturized multiplexed NanoArray assays.
Please visit www.nanoink.net/nanobio to view this exciting and informative video production or for
more information please call NanoInk Nano BioDiscovery at (847)679-3432.
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and
applications development for the life science and semiconductor industries. Using Dip Pen Nanolithography®
(DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily
create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique
brings sophisticated nanofabrication to the laboratory desktop. Located in the new Illinois Science +
Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide
and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde,
University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign.
For more information on products and services offered by NanoInk, Inc., see www.nanoink.net
NanoInk, the NanoInk logo, Dip Pen Nanolithography and DPN are trademarks or registered
trademarks of NanoInk, Inc.
###